These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20041365)

  • 1. [The role of osteoprotegerin and vitamin D in thyroid pathology].
    Tuchendler D; Bolanowski M
    Endokrynol Pol; 2009; 60(6):470-5. PubMed ID: 20041365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral and bone metabolism in thyroid disease: a review.
    Auwerx J; Bouillon R
    Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--thyroid hormones].
    Kiriyama T; Okamoto S; Nagataki S
    Nihon Rinsho; 1986 Nov; 44(11):2399-403. PubMed ID: 3546791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteoporosis in thyroid disease].
    Mitsuma T
    Nihon Rinsho; 1990 Dec; 48(12):2898-903. PubMed ID: 2086852
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid hormone receptor expression and action in bone.
    Bland R
    Clin Sci (Lond); 2000 Feb; 98(2):217-40. PubMed ID: 10657279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis].
    Ambroszkiewicz J; Gajewska J; Sands D; Chełchowska M; Ołtarzewski M; Laskowska-Klita T
    Med Wieku Rozwoj; 2012; 16(2):117-23. PubMed ID: 22971655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New data on calcium and bone metabolism].
    Masek O
    Vnitr Lek; 1970 Feb; 16(2):150-67. PubMed ID: 4908248
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
    Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
    Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial.
    Hooshmand S; Brisco JR; Arjmandi BH
    Br J Nutr; 2014 Jul; 112(1):55-60. PubMed ID: 24780728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of somatomedins and growth hormone in relation to bone metabolism in acromegaly and thyroid dysfunction.
    Bijlsma JW; Duursma SA
    Clin Exp Rheumatol; 1986; 4(2):105-10. PubMed ID: 3731567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-related effects of contaminants in seals may be associated with vitamin D and thyroid hormones.
    Routti H; Nyman M; Jenssen BM; Bäckman C; Koistinen J; Gabrielsen GW
    Environ Toxicol Chem; 2008 Apr; 27(4):873-80. PubMed ID: 18333671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease & osteoimmunology--is vitamin D the cross-talk co-ordinator?
    Harinarayan CV
    Indian J Med Res; 2009 Aug; 130(2):108-11. PubMed ID: 19797805
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology).
    Bordier P; Miravet L; Matrajt H; Hioco D; Ryckewaert A
    Proc R Soc Med; 1967 Nov; 60(11 Part 1):1132-4. PubMed ID: 6060707
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid Hormone Actions and Bone Remodeling - The Role of the Wnt Signaling Pathway.
    Lademann F; Tsourdi E; Hofbauer LC; Rauner M
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):450-454. PubMed ID: 31958849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin: relevant side effects.
    Kutt H; Solomon GE
    Adv Neurol; 1980; 27():435-45. PubMed ID: 6990706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Updates on Lifestyle-Related Diseases and Bone Metabolism. A possible involvement of vitamin D, a pivotal player in bone metabolism, in lifestyle-related diseases].
    Takeuchi Y
    Clin Calcium; 2014 Nov; 24(11):1695-700. PubMed ID: 25355154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iodine metabolism and thyroid hormones in the normal state and in pathology].
    Turakulov IaKh
    Probl Endokrinol (Mosk); 1986; 32(5):78-85. PubMed ID: 3538010
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis.
    Stanisławowski M; Wiśniewski P; Guzek M; Wierzbicki PM; Adrych K; Smoczyński M; Sworczak K; Celiński K; Kmieć Z
    J Crohns Colitis; 2014 Aug; 8(8):802-10. PubMed ID: 24439762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue sensitivity to drugs in disease states.
    Lowenthal DT
    Med Clin North Am; 1974 Sep; 58(5):1111-9. PubMed ID: 4371709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.